Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) fundamentals
Apollo Hospitals Enterprise Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as APOLLOHOSP (ISIN INE437A01024). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Apollo Hospitals Enterprise Ltd. does
Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 plus beds across 73 hospitals, 5000 plus pharmacies and 378 plus clinics and diagnostic centers, as well as 200 telemedicine centers.
Valuation and market data
| Last close | ₹8836.00 |
|---|---|
| Market capitalisation | ₹1.31 lakh crore |
| Enterprise value | ₹1.36 lakh crore |
| P/E (TTM) | 65.43 |
| Price to book | 13.14 |
| Price to sales (TTM) | 2.90 |
| Book value per share | ₹672.57 |
| Dividend yield | 22.63% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed Jan 10 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹9,698 crore | ₹1,946 crore | ₹1,493 crore | 103.81 |
| Mar 2025 | ₹8,550 crore | ₹1,689 crore | ₹1,296 crore | 90.15 |
| Mar 2024 | ₹7,454 crore | ₹1,329 crore | ₹1,011 crore | 70.28 |
| Mar 2023 | ₹6,676 crore | ₹1,228 crore | ₹1,085 crore | 75.45 |
| Mar 2022 | ₹6,145 crore | ₹852 crore | ₹573 crore | 46.25 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 28.0% |
|---|---|
| Foreign institutions (FII) | 41.5% |
| Mutual funds | 17.3% |
| Other domestic institutions | 6.4% |
| Retail and others | 6.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.